Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 18;13:851620. doi: 10.3389/fimmu.2022.851620

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Won, Gilotra, Wood, Hughes, Talor, Lovell, Milstone, Steenbergen and Čiháková

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Elevation of Th1-type cytokines and chemokine in patient with myopericarditis after COVID-19 vaccination. (A) Representative image of H&E staining on endomyocardial biopsy from the patient with COVID-19 vaccine-related myopericarditis. Biopsy was collected on day 3 after COVID-19 mRNA vaccine. Scale bar: 12.5 µm. (B, C) Representative images of immunohistochemistry staining for CD68 (B) and CD3 (C) on endomyocardial biopsy of the patient. Scale bars: 12.5 µm. (D–F) Plasma cytokine and chemokine levels measured by multiplex cytokine assay in the patient with myopericarditis on days 3 (D3) and 4 (D4) after COVID-19 mRNA vaccination. As controls, five healthy controls (Healthy) and five individuals who had been vaccinated in the past 2 to 3 days (Vaccine) were tested.